CREDIT SUISSE AG/ - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 21 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q4 2021$317,000
-42.7%
59,172
-33.4%
0.00%
Q3 2021$553,000
+137.3%
88,829
+130.0%
0.00%
Q2 2021$233,000
-29.0%
38,623
+15.6%
0.00%
Q1 2021$328,00033,4230.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q1 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 1,058,035$2,9310.15%
Gradient Capital Advisors, LLC 26,808$74,2580.03%
Federation des caisses Desjardins du Quebec 57,974$160,5880.00%
WEST PACES ADVISORS INC. 1,665$4,6120.00%
Belvedere Trading LLC 3,400$9,4180.00%
Belvedere Trading LLC 2,000$5,5400.00%
Belvedere Trading LLC 9,739$26,9770.00%
CITIGROUP INC 7$190.00%
GEODE CAPITAL MANAGEMENT, LLC 17,484$48,4300.00%
CIBC WORLD MARKET INC. 42,427$1180.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders